Old,drugsReports on the results of two new American studies into the treatment of heart disease. Findings of one that adding a dose of isosorbide dinitrate plus hydralazine to standard treatment for advanced heart failure can help black people live longer; Second study which offered no extra ...
(DrugsUsedInHeartFailure)心力衰竭（heartfailure,HF）:由于任何原因的初始心肌损伤（心肌梗死、血液动力负荷过重、炎症），引起心 肌结构和功能的变化，最后导致心室射血/ 充盈功能低下。ChronicHeartFailure(CHF)发病率1%～4%，高龄者达10%。心功能为NYHAⅡ～Ⅲ级者年死亡率 约10%～20%，Ⅳ级者年死亡率高达40...
1抗慢性心功能不全药物used in congestive heart failure)(Drugs 收藏 分享 下载 举报 用客户端打开
A novel study from Karolinska Institutesuggests that RAS-antagonists, common drugs for patients with heart failure, may benefit also patients who have concomitant kidney disease, a group previously not studied. These drugs have proven effect in heart failure, but patients with kidney disease were exc...
The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model. To evaluate the cost effectiveness and cost utility of the use of valsartan in addition to standard therapy for the treatment of patients with chronic heart failure with low...
heart attackandheart failureare the principal cause of death in the UK and around the world. Drugs that help tolower blood pressure(antihypertensives) andcholesterol levels(statins) are safe and effective, yet current guidelines for preventing cardiovascular disease focus only on people aged 40-74 ...
HEART FAILURE:Treatment strategies for heart failure: β blockers and antiarrhythmics The role of β blockers and antiarrhythmic drugs in the management of patients with heart failure is reviewed. β Blockers Although several investigators s... AP Maggioni - 《Heart Official Journal of the British...
Think vaping is the healthy alternative to smoking Think again A new study finds it raises people s odds for heart failure. More and more studies are linking e-
followed for a median of 2.3 years. The primary endpoint was a composite ofcardiovascular deathor worsening heart failure. Dapagliflozin significantly reduced the primary composite endpoint by 18 percent. Worsening heart failure occurred in 368 participants (11.8 percent) in the dapagliflozin group compar...
The adverse reaction was not limited to the elderly – one-quarter of cases occurred in people younger than 60. Heart failure occurred equally among men and women. The product label for both drugs warns against their use in patients with more severe cases of heart failure. The label also cau...